首页> 美国卫生研究院文献>Journal of Cardiology Cases >Takotsubo cardiomyopathy with transient left ventricular obstruction successfully treated with cibenzoline succinate: A case report
【2h】

Takotsubo cardiomyopathy with transient left ventricular obstruction successfully treated with cibenzoline succinate: A case report

机译:Takotsubo心肌病合并暂时性左心室阻塞的琥珀酸cibenzoline成功治疗一例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An 84-year-old woman was urgently referred to our hospital owing to persistent malaise and chest pain. Takotsubo cardiomyopathy was diagnosed following transthoracic echocardiography, emergency coronary angiography, and left ventriculography. A left ventricular pressure tracing during cardiac catheterization revealed a 72 mmHg-intraventricular pressure gradient (LVPG). Although β-blockers are effective at reducing LVPG in takotsubo cardiomyopathy, such treatment was contraindicated in our patient owing to her history of bronchial asthma. Therefore, we administered intravenous cibenzoline succinate to attenuate her LVPG. The LVPG decreased to 18 mmHg within 10 min after intravenous cibenzoline succinate administration. During her subsequent hospitalization, the patient showed excellent functional recovery, without any complications. Left ventriculography, performed 21 days after admission, showed normal wall motion and a left ventricular ejection fraction of 68%.<>Learning objective: The prognosis of takotsubo cardiomyopathy is generally good, however, fatal complications have been reported. Our case demonstrated a LVPG of 72 mmHg, and β-blockers were contraindicated because of bronchial asthma. Intravenous cibenzoline administration resulted in successful attenuation of the patient's LVPG. The present case suggests that cibenzoline might be effective for the treatment of takotsubo cardiomyopathy, especially in those contraindicated for β-blocker therapy.>
机译:由于持续不适和胸痛,一名84岁妇女被紧急转诊到我们医院。经胸超声心动图检查,急诊冠状动脉造影检查和左心室造影检查后诊断为Takotsubo心肌病。心脏导管插入术期间的左心室压力示踪显示脑室内压力梯度(LVPG)为72mmHg。尽管β受体阻滞剂可有效降低takotsubo心肌病中的LVPG,但由于她的支气管哮喘史,这种治疗被禁忌。因此,我们静脉内注射琥珀酸cibenzoline来减轻她的LVPG。静脉给予琥珀酸环苯甲酸后10分钟内,LVPG降至18mmHg。在其随后的住院期间,患者表现出出色的功能恢复,没有任何并发​​症。入院后21天进行的左心室造影显示壁运动正常,左心室射血分数为68%。 strong>学习目的: takotsubo心肌病的预后总体良好,但是已报道了致命的并发症。我们的病例显示LVPG为72 mmHg,并且由于支气管哮喘禁用了β受体阻滞剂。静脉注射cibenzoline可成功减轻患者的LVPG。目前的情况表明,cibenzoline可能对takotsubo心肌病的治疗有效,特别是在那些β受体阻滞剂禁忌的患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号